Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major.

ABSTRACT:

SUBMITTER: Casu C 

PROVIDER: S-EPMC5792284 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature